80 FR 13012 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 48 (March 12, 2015)

Page Range		13012-13013
FR Document		2015-05576

Federal Register, Volume 80 Issue 48 (Thursday, March 12, 2015)

[Federal Register Volume 80, Number 48 (Thursday, March 12, 2015)]
[Notices]
[Pages 13012-13013]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-05576]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to (FOA) DP15-009, Improving Surveillance and 
Prevention of Epilepsy Burden in U.S. Communities.

    Time and Date: 10:00 a.m.--6:00 p.m., March 31, 2015 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Improving Surveillance and Prevention of Epilepsy 
Burden in US Communities'', DP15-009.
    Contact Person for More Information: M. Chris Langub, Ph.D., 
Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop 
F-80, Atlanta, Georgia 30341, Telephone: (770) 488-3585, 
EEO6@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and

[[Page 13013]]

Prevention and the Agency for Toxic Substances and Disease Registry.


Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-05576 Filed 3-11-15; 8:45 am]
 BILLING CODE 4163-18-P

13012 Federal Register / Vol. 80, No. 48 / Thursday, March 12, 2015 / Notices

OS specifically requests comments on 7W602, Rockville, MD 20850, (Telephone Contact Person for More Information:
(1) the necessity and utility of the Conference Call). M. Chris Langub, Ph.D., Scientific
proposed information collection for the Contact Person: Delia Tang, Ph.D., Review Officer, CDC, 4770 Buford
proper performance of the agency’s Scientific Review Officer, Research Program Highway NE., Mailstop F–80, Atlanta,
Review Branch, Division of Extramural
functions, (2) the accuracy of the Activities, National Cancer Institute, 9609
Georgia 30341, Telephone: (770) 488–
estimated burden, (3) ways to enhance Medical Center Drive, Room 7W602, 3585, EEO6@cdc.gov.
the quality, utility, and clarity of the Bethesda, MD 20892, 240–276–6456, The Director, Management Analysis
information to be collected, and (4) the tangd@.mail.nih.gov. and Services Office, has been delegated
use of automated collection techniques Information is also available on the the authority to sign Federal Register
or other forms of information Institute’s/Center’s home page: http://
notices pertaining to announcements of
technology to minimize the information deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional meetings and other committee
collection burden. management activities, for both the
information for the meeting will be posted
Terry S. Clark, when available. Centers for Disease Control and
Deputy Information Collection Clearance (Catalogue of Federal Domestic Assistance Prevention and the Agency for Toxic
Officer. Program Nos. 93.392, Cancer Construction; Substances and Disease Registry.
[FR Doc. 2015–05624 Filed 3–11–15; 8:45 am] 93.393, Cancer Cause and Prevention
Elaine L. Baker,
BILLING CODE 4150–03–P
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer Director, Management Analysis and Services
Treatment Research; 93.396, Cancer Biology Office, Centers for Disease Control and
Research; 93.397, Cancer Centers Support; Prevention.
DEPARTMENT OF HEALTH AND 93.398, Cancer Research Manpower; 93.399, [FR Doc. 2015–05574 Filed 3–11–15; 8:45 am]
HUMAN SERVICES Cancer Control, National Institutes of Health, BILLING CODE 4163–18–P
HHS)
National Institutes of Health
Dated: March 6, 2015.
National Cancer Institute; Notice of Melanie J. Gray, DEPARTMENT OF HEALTH AND
Closed Meetings Program Analyst, Office of Federal Advisory HUMAN SERVICES
Committee Policy.
Pursuant to section 10(d) of the [FR Doc. 2015–05568 Filed 3–11–15; 8:45 am] Centers for Disease Control and
Federal Advisory Committee Act, as BILLING CODE 4140–01–P
Prevention
amended (5 U.S.C. App.), notice is
hereby given of the following meetings. Disease, Disability, and Injury
The meetings will be closed to the DEPARTMENT OF HEALTH AND Prevention and Control Special
public in accordance with the HUMAN SERVICES Emphasis Panel (SEP): Initial Review
provisions set forth in sections
Centers for Disease Control and In accordance with Section 10(a)(2) of
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Prevention the Federal Advisory Committee Act
as amended. The grant applications and
(Pub. L. 92–463), the Centers for Disease
the discussions could disclose
Disease, Disability, and Injury Control and Prevention (CDC)
confidential trade secrets or commercial
Prevention and Control Special announces a meeting for the initial
property such as patentable material,
Emphasis Panel (SEP): Initial Review review of applications in response to
and personal information concerning
(FOA) DP15–009, Improving
individuals associated with the grant In accordance with section 10(a)(2) of Surveillance and Prevention of Epilepsy
applications, the disclosure of which the Federal Advisory Committee Act Burden in U.S. Communities.
would constitute a clearly unwarranted (Pub. L. 92–463), the Centers for Disease
invasion of personal privacy. Control and Prevention (CDC) Time and Date: 10:00 a.m.—6:00 p.m.,
announces a meeting for the initial March 31, 2015 (Closed).
Name of Committee: National Cancer
review of applications in response to Place: Teleconference.
Institute Special Emphasis Panel; NCI
Omnibus R03 & R21 SEP–12. (FOA) DP15–005, Evaluation of a Status: The meeting will be closed to the
Date: April 30, 2015. Stepped Care Approach for Perinatal public in accordance with provisions set
Time: 8:00 a.m. to 6:00 p.m. Depression Treatment in Obstetrics and forth in Section 552b(c)(4) and (6), Title 5
Agenda: To review and evaluate grant U.S.C., and the Determination of the Director,
Gynecology Clinics.
applications. Management Analysis and Services Office,
Time and Date: 10:00 a.m.–6:00 p.m.,
Place: Hyatt Regency Bethesda, One CDC, pursuant to Public Law 92–463.
Bethesda Metro Center, 7400 Wisconsin
April 1, 2015 (Closed).
Matters for Discussion: The meeting will
Avenue, Bethesda, MD 20814. Place: Teleconference.
include the initial review, discussion, and
Contact Person: Dona Love, Ph.D. Status: The meeting will be closed to
evaluation of applications received in
Scientific Review Officer, Special Review the public in accordance with
response to ‘‘Improving Surveillance and
Branch, Division of Extramural Activities, provisions set forth in section 552b(c)(4) Prevention of Epilepsy Burden in US
National Cancer Institute, 9609 Medical and (6), title 5 U.S. C., and the Communities’’, DP15–009.
Center Drive, Room 7W236, Bethesda, MD Determination of the Director, Contact Person for More Information: M.
20850, 240–276–5264, donalove@ Management Analysis and Services
mail.nih.gov. Chris Langub, Ph.D., Scientific Review
Office, CDC, pursuant to Pub. L. 92–463.
asabaliauskas on DSK5VPTVN1PROD with NOTICES

Officer, CDC, 4770 Buford Highway, NE.,
Name of Committee: National Cancer Matters for Discussion: The meeting Mailstop F–80, Atlanta, Georgia 30341,
Institute Special Emphasis Panel; Omnibus will include the initial review,
SEP–10. Telephone: (770) 488–3585, EEO6@cdc.gov.
discussion, and evaluation of The Director, Management Analysis and
Date: April 30, 2015.
Time: 9:00 a.m. to 6:00 p.m.
applications received in response to Services Office, has been delegated the
Agenda: To review and evaluate grant ‘‘Evaluation of a Stepped Care Approach authority to sign Federal Register notices
applications. for Perinatal Depression Treatment in pertaining to announcements of meetings and
Place: National Cancer Institute Shady Obstetrics and Gynecology Clinics’’, other committee management activities, for
Grove, 9609 Medical Center Drive, Room DP15–005. both the Centers for Disease Control and

VerDate Sep<11>2014 17:40 Mar 11, 2015 Jkt 235001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\12MRN1.SGM 12MRN1

Federal Register / Vol. 80, No. 48 / Thursday, March 12, 2015 / Notices 13013

Prevention and the Agency for Toxic on those who are to respond, including motivation to participate in that
Substances and Disease Registry. the use of appropriate automated, research. In addition, the knowledge
electronic, mechanical, or other gained will be invaluable to the field of
Elaine L. Baker, technological collection techniques or clinical research given the need for
Director, Management Analysis and Services other forms of information technology. more clinical trials with youth.
Office, Centers for Disease Control and To Submit Comments and For Further Specifically, the proposed web-based
Prevention. Information: To obtain a copy of the resource will be an interactive,
[FR Doc. 2015–05576 Filed 3–11–15; 8:45 am] data collection plans and instruments, multimedia, developmentally
BILLING CODE 4163–18–P submit comments in writing, or request appropriate resource for youth to be
more information on the proposed educated about pediatric clinical trials.
project, contact: Ms. Victoria The resource will be developed for
DEPARTMENT OF HEALTH AND Pemberton, National Heart, Lung, and
HUMAN SERVICES youth aged 8 to 14 years. The theme of
Blood Institute, National Institutes of ‘‘investigative cyber-reporting’’ will be
Health, 6701 Rockledge Dr., Room 8102, used throughout and will include youth
National Institutes of Health MSC 7940, Bethesda, MD 20892–7940, making a series of decisions about
Proposed Collection; 60-Day Comment or call non-toll-free number 301–435–
different aspects of participating in
Request Web-Based Resource for 0510, or Email your request, including
clinical research studies. Youth will be
Youth About Clinical Research (NHLBI) your address to
tasked with the responsibility of
pembertonv@nhlbi.nih.gov. Formal
learning all they can about clinical
SUMMARY: In compliance with the requests for additional plans and
instruments must be requested in research trials in order to facilitate their
requirement of Section 3506(c)(2)(A) of
writing. knowledge and decision-making
the Paperwork Reduction Act of 1995,
processes. Language typically used in
for opportunity for public comment on DATES: Comment Due Date: Comments journalism and design elements
proposed data collection projects, the regarding this information collection are reminiscent of journalism will be
National Heart, Lung and Blood best assured of having their full effect if incorporated into the content, design,
Institute (NHLBI), National Institutes of received within 60 days of the date of and layout of the resource. There are
Health (NIH), will publish periodic this publication. three main components that will
summaries of proposed projects to be Proposed Collection: Web-based comprise the web-based resource. These
submitted to the Office of Management Resource for Youth about Clinical include an interactive leaning module,
and Budget (OMB) for review and Research (NHLBI), 0925-New, National full length video testimonials, and an
approval. Heart, Lung, and Blood Institute electronic comic book. The benefits and
Written comments and/or suggestions (NHLBI), National Institutes of Health necessities for this particular research
from the public and affected agencies (NIH). on pediatric clinical trials are congruent
are invited on one or more of the Need and Use of Information
with NHLBI’s research goals and
following points: (1) Whether the Collection: The purpose and use of the
mission statement: Attempting to assist
proposed collection of information is information collection for this project is
in the enhancement of the health of
necessary for the proper performance of to develop a comprehensive web-based
individuals so that they can live longer
the function of the agency, including resource for youth with chronic
whether the information will have and more fulfilling lives. The current
illnesses or diseases that will attempt to
practical utility; (2) The accuracy of the increase knowledge, self-efficacy, and lack of knowledge surrounding pediatric
agency’s estimate of the burden of the positive attitudes towards participation clinical trials can be dangerous and
proposed collection of information, in various clinical trials and research. unhealthy towards the lives of youth,
including the validity of the As a result of the proposed web-based becoming a large public health need.
methodology and assumptions used; (3) resource, the knowledge gained from OMB approval is requested for 3
Ways to enhance the quality, utility, and developing and testing this web-based years. There are no costs to respondents
clarity of the information to be resource will ultimately help equip other than their time. The total
collected; and (4) Ways to minimize the youth to make informed decisions about estimated annualized burden hours are
burden of the collection of information clinical research and increase 164.
ESTIMATES OF HOUR BURDEN
Average
Number of
Number of burden per Total annual
Form name Type of respondent responses per
respondents response burden hour
respondent (in hours)

Individual Interview Questionnaire .... Individual Interviews Study .............. 9 1 2 18
One-to-One Evaluation Question- One-to-One Evaluation Study .......... 5 1 2 10
naire.
Pre-Post Study Questionnaire .......... Pre-Post Feedback Study ................ 34 1 4 136
asabaliauskas on DSK5VPTVN1PROD with NOTICES

Dated: February 23, 2015.
Lynn Susulske,
NHLBI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2015–05592 Filed 3–11–15; 8:45 am]
BILLING CODE 4140–01–P

VerDate Sep<11>2014 18:23 Mar 11, 2015 Jkt 235001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\12MRN1.SGM 12MRN1

Document Created: 2018-02-21 09:35:53
Document Modified: 2018-02-21 09:35:53

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		10:00 a.m.--6:00 p.m., March 31, 2015 (Closed).
FR Citation		80 FR 13012

80 FR 13012 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 80, Issue 48 (March 12, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention